nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—CYP1A2—Carmustine—malignant glioma	0.247	1	CbGbCtD
Zolmitriptan—HTR1D—meninx—malignant glioma	0.0593	0.196	CbGeAlD
Zolmitriptan—HTR1B—dura mater—malignant glioma	0.0563	0.187	CbGeAlD
Zolmitriptan—HTR1D—dura mater—malignant glioma	0.0545	0.181	CbGeAlD
Zolmitriptan—Adverse reaction—Carmustine—malignant glioma	0.0273	0.0798	CcSEcCtD
Zolmitriptan—Reaction aggravation—Carmustine—malignant glioma	0.0273	0.0798	CcSEcCtD
Zolmitriptan—HTR1B—telencephalic ventricle—malignant glioma	0.014	0.0465	CbGeAlD
Zolmitriptan—HTR1D—telencephalic ventricle—malignant glioma	0.0136	0.045	CbGeAlD
Zolmitriptan—Melatonin—ASMT—malignant glioma	0.0136	0.899	CrCbGaD
Zolmitriptan—HTR1A—telencephalic ventricle—malignant glioma	0.0113	0.0375	CbGeAlD
Zolmitriptan—Vasospasm—Carmustine—malignant glioma	0.00838	0.0245	CcSEcCtD
Zolmitriptan—HTR1F—telencephalon—malignant glioma	0.00823	0.0273	CbGeAlD
Zolmitriptan—Hyperacusis—Temozolomide—malignant glioma	0.00742	0.0217	CcSEcCtD
Zolmitriptan—HTR1B—blood vessel—malignant glioma	0.00695	0.023	CbGeAlD
Zolmitriptan—HTR1D—blood vessel—malignant glioma	0.00673	0.0223	CbGeAlD
Zolmitriptan—Cerebral ischaemia—Temozolomide—malignant glioma	0.00572	0.0167	CcSEcCtD
Zolmitriptan—Transient ischaemic attack—Temozolomide—malignant glioma	0.00548	0.016	CcSEcCtD
Zolmitriptan—HTR1F—central nervous system—malignant glioma	0.00468	0.0155	CbGeAlD
Zolmitriptan—Myasthenia—Carmustine—malignant glioma	0.00455	0.0133	CcSEcCtD
Zolmitriptan—Parosmia—Temozolomide—malignant glioma	0.00426	0.0125	CcSEcCtD
Zolmitriptan—Burning sensation—Carmustine—malignant glioma	0.00412	0.0121	CcSEcCtD
Zolmitriptan—Apathy—Temozolomide—malignant glioma	0.00387	0.0113	CcSEcCtD
Zolmitriptan—Flat affect—Temozolomide—malignant glioma	0.00384	0.0112	CcSEcCtD
Zolmitriptan—HTR1B—brainstem—malignant glioma	0.0038	0.0126	CbGeAlD
Zolmitriptan—Scotoma—Carmustine—malignant glioma	0.00377	0.011	CcSEcCtD
Zolmitriptan—Menorrhagia—Temozolomide—malignant glioma	0.00374	0.0109	CcSEcCtD
Zolmitriptan—HTR1F—brain—malignant glioma	0.00371	0.0123	CbGeAlD
Zolmitriptan—HTR1D—brainstem—malignant glioma	0.00368	0.0122	CbGeAlD
Zolmitriptan—Necrosis—Carmustine—malignant glioma	0.00365	0.0107	CcSEcCtD
Zolmitriptan—Scotoma—Temozolomide—malignant glioma	0.00364	0.0107	CcSEcCtD
Zolmitriptan—Hyperaesthesia—Temozolomide—malignant glioma	0.00352	0.0103	CcSEcCtD
Zolmitriptan—HTR1B—telencephalon—malignant glioma	0.00337	0.0112	CbGeAlD
Zolmitriptan—Speech disorder—Carmustine—malignant glioma	0.00333	0.00973	CcSEcCtD
Zolmitriptan—HTR1D—telencephalon—malignant glioma	0.00326	0.0108	CbGeAlD
Zolmitriptan—Speech disorder—Temozolomide—malignant glioma	0.00322	0.00941	CcSEcCtD
Zolmitriptan—Thinking abnormal—Carmustine—malignant glioma	0.00313	0.00915	CcSEcCtD
Zolmitriptan—HTR1A—brainstem—malignant glioma	0.00306	0.0102	CbGeAlD
Zolmitriptan—MAOA—embryo—malignant glioma	0.00305	0.0101	CbGeAlD
Zolmitriptan—Coordination abnormal—Carmustine—malignant glioma	0.00291	0.00853	CcSEcCtD
Zolmitriptan—Neck pain—Carmustine—malignant glioma	0.0029	0.00847	CcSEcCtD
Zolmitriptan—Coordination abnormal—Temozolomide—malignant glioma	0.00282	0.00824	CcSEcCtD
Zolmitriptan—MAOA—brainstem—malignant glioma	0.0028	0.00928	CbGeAlD
Zolmitriptan—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00277	0.00809	CcSEcCtD
Zolmitriptan—Vaginal inflammation—Temozolomide—malignant glioma	0.00277	0.00809	CcSEcCtD
Zolmitriptan—HTR1A—telencephalon—malignant glioma	0.00272	0.00901	CbGeAlD
Zolmitriptan—MAOA—retina—malignant glioma	0.0027	0.00895	CbGeAlD
Zolmitriptan—Neuropathy—Carmustine—malignant glioma	0.00269	0.00786	CcSEcCtD
Zolmitriptan—Vaginal infection—Temozolomide—malignant glioma	0.00261	0.00764	CcSEcCtD
Zolmitriptan—Neuropathy—Temozolomide—malignant glioma	0.0026	0.0076	CcSEcCtD
Zolmitriptan—Neoplasm—Carmustine—malignant glioma	0.00259	0.00757	CcSEcCtD
Zolmitriptan—Dry eye—Temozolomide—malignant glioma	0.00255	0.00747	CcSEcCtD
Zolmitriptan—Neoplasm—Temozolomide—malignant glioma	0.0025	0.00732	CcSEcCtD
Zolmitriptan—MAOA—telencephalon—malignant glioma	0.00248	0.00823	CbGeAlD
Zolmitriptan—Mental disability—Carmustine—malignant glioma	0.00248	0.00727	CcSEcCtD
Zolmitriptan—HTR1B—midbrain—malignant glioma	0.00242	0.00802	CbGeAlD
Zolmitriptan—Mental disability—Temozolomide—malignant glioma	0.0024	0.00702	CcSEcCtD
Zolmitriptan—Thrombophlebitis—Carmustine—malignant glioma	0.0024	0.00702	CcSEcCtD
Zolmitriptan—HTR1B—spinal cord—malignant glioma	0.00236	0.00783	CbGeAlD
Zolmitriptan—Ear pain—Temozolomide—malignant glioma	0.00235	0.00688	CcSEcCtD
Zolmitriptan—HTR1D—midbrain—malignant glioma	0.00234	0.00777	CbGeAlD
Zolmitriptan—Thrombophlebitis—Temozolomide—malignant glioma	0.00232	0.00678	CcSEcCtD
Zolmitriptan—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00231	0.00675	CcSEcCtD
Zolmitriptan—Eye pain—Carmustine—malignant glioma	0.0023	0.00673	CcSEcCtD
Zolmitriptan—Gastroenteritis—Temozolomide—malignant glioma	0.00227	0.00663	CcSEcCtD
Zolmitriptan—Eye pain—Temozolomide—malignant glioma	0.00222	0.00651	CcSEcCtD
Zolmitriptan—Amnesia—Carmustine—malignant glioma	0.00221	0.00647	CcSEcCtD
Zolmitriptan—Amnesia—Temozolomide—malignant glioma	0.00214	0.00625	CcSEcCtD
Zolmitriptan—Thirst—Temozolomide—malignant glioma	0.00211	0.00617	CcSEcCtD
Zolmitriptan—Diplopia—Carmustine—malignant glioma	0.00208	0.00608	CcSEcCtD
Zolmitriptan—Diplopia—Temozolomide—malignant glioma	0.00201	0.00587	CcSEcCtD
Zolmitriptan—Face oedema—Carmustine—malignant glioma	0.00201	0.00587	CcSEcCtD
Zolmitriptan—Affect lability—Temozolomide—malignant glioma	0.00198	0.00578	CcSEcCtD
Zolmitriptan—Ataxia—Carmustine—malignant glioma	0.00195	0.00571	CcSEcCtD
Zolmitriptan—HTR1A—midbrain—malignant glioma	0.00195	0.00647	CbGeAlD
Zolmitriptan—MAOA—medulla oblongata—malignant glioma	0.00195	0.00647	CbGeAlD
Zolmitriptan—Face oedema—Temozolomide—malignant glioma	0.00194	0.00567	CcSEcCtD
Zolmitriptan—HTR1B—central nervous system—malignant glioma	0.00192	0.00635	CbGeAlD
Zolmitriptan—HTR1A—spinal cord—malignant glioma	0.00191	0.00631	CbGeAlD
Zolmitriptan—Mood swings—Temozolomide—malignant glioma	0.0019	0.00556	CcSEcCtD
Zolmitriptan—Ataxia—Temozolomide—malignant glioma	0.00189	0.00552	CcSEcCtD
Zolmitriptan—Dehydration—Temozolomide—malignant glioma	0.00187	0.00546	CcSEcCtD
Zolmitriptan—HTR1D—central nervous system—malignant glioma	0.00185	0.00615	CbGeAlD
Zolmitriptan—Muscular weakness—Carmustine—malignant glioma	0.00183	0.00536	CcSEcCtD
Zolmitriptan—Dysphagia—Carmustine—malignant glioma	0.0018	0.00525	CcSEcCtD
Zolmitriptan—MAOA—midbrain—malignant glioma	0.00178	0.00591	CbGeAlD
Zolmitriptan—Muscular weakness—Temozolomide—malignant glioma	0.00177	0.00518	CcSEcCtD
Zolmitriptan—MAOA—spinal cord—malignant glioma	0.00174	0.00577	CbGeAlD
Zolmitriptan—Dysphagia—Temozolomide—malignant glioma	0.00174	0.00508	CcSEcCtD
Zolmitriptan—Bronchitis—Temozolomide—malignant glioma	0.00167	0.00488	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Carmustine—malignant glioma	0.00162	0.00474	CcSEcCtD
Zolmitriptan—Pneumonia—Carmustine—malignant glioma	0.00161	0.00471	CcSEcCtD
Zolmitriptan—Pollakiuria—Temozolomide—malignant glioma	0.0016	0.00469	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Temozolomide—malignant glioma	0.00158	0.00463	CcSEcCtD
Zolmitriptan—Weight increased—Temozolomide—malignant glioma	0.00158	0.00462	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Carmustine—malignant glioma	0.00157	0.00459	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Temozolomide—malignant glioma	0.00157	0.00458	CcSEcCtD
Zolmitriptan—Stomatitis—Carmustine—malignant glioma	0.00156	0.00457	CcSEcCtD
Zolmitriptan—Urinary tract infection—Carmustine—malignant glioma	0.00156	0.00455	CcSEcCtD
Zolmitriptan—Pneumonia—Temozolomide—malignant glioma	0.00156	0.00455	CcSEcCtD
Zolmitriptan—HTR1A—central nervous system—malignant glioma	0.00155	0.00512	CbGeAlD
Zolmitriptan—Eletriptan—PTGS1—malignant glioma	0.00153	0.101	CrCbGaD
Zolmitriptan—HTR1B—brain—malignant glioma	0.00152	0.00504	CbGeAlD
Zolmitriptan—Neuropathy peripheral—Temozolomide—malignant glioma	0.00152	0.00444	CcSEcCtD
Zolmitriptan—HTR1A—cerebellum—malignant glioma	0.00151	0.00501	CbGeAlD
Zolmitriptan—Stomatitis—Temozolomide—malignant glioma	0.00151	0.00441	CcSEcCtD
Zolmitriptan—Urinary tract infection—Temozolomide—malignant glioma	0.0015	0.0044	CcSEcCtD
Zolmitriptan—HTR1D—brain—malignant glioma	0.00147	0.00488	CbGeAlD
Zolmitriptan—Sinusitis—Temozolomide—malignant glioma	0.00145	0.00425	CcSEcCtD
Zolmitriptan—Hallucination—Carmustine—malignant glioma	0.00143	0.00418	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Carmustine—malignant glioma	0.00143	0.00418	CcSEcCtD
Zolmitriptan—Oedema peripheral—Carmustine—malignant glioma	0.00142	0.00414	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Carmustine—malignant glioma	0.00141	0.00413	CcSEcCtD
Zolmitriptan—MAOA—central nervous system—malignant glioma	0.00141	0.00468	CbGeAlD
Zolmitriptan—Hallucination—Temozolomide—malignant glioma	0.00138	0.00404	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Temozolomide—malignant glioma	0.00138	0.00404	CcSEcCtD
Zolmitriptan—MAOA—cerebellum—malignant glioma	0.00138	0.00457	CbGeAlD
Zolmitriptan—Pharyngitis—Temozolomide—malignant glioma	0.00138	0.00403	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Temozolomide—malignant glioma	0.00137	0.00401	CcSEcCtD
Zolmitriptan—Oedema peripheral—Temozolomide—malignant glioma	0.00137	0.004	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Temozolomide—malignant glioma	0.00136	0.00399	CcSEcCtD
Zolmitriptan—Urethral disorder—Temozolomide—malignant glioma	0.00136	0.00398	CcSEcCtD
Zolmitriptan—Tinnitus—Temozolomide—malignant glioma	0.00129	0.00379	CcSEcCtD
Zolmitriptan—Cardiac disorder—Temozolomide—malignant glioma	0.00129	0.00377	CcSEcCtD
Zolmitriptan—Arrhythmia—Carmustine—malignant glioma	0.00128	0.00376	CcSEcCtD
Zolmitriptan—Angiopathy—Temozolomide—malignant glioma	0.00126	0.00369	CcSEcCtD
Zolmitriptan—Immune system disorder—Temozolomide—malignant glioma	0.00125	0.00367	CcSEcCtD
Zolmitriptan—Erythema—Carmustine—malignant glioma	0.00125	0.00366	CcSEcCtD
Zolmitriptan—Chills—Temozolomide—malignant glioma	0.00125	0.00365	CcSEcCtD
Zolmitriptan—HTR1A—brain—malignant glioma	0.00123	0.00407	CbGeAlD
Zolmitriptan—Back pain—Carmustine—malignant glioma	0.00121	0.00354	CcSEcCtD
Zolmitriptan—Erythema—Temozolomide—malignant glioma	0.00121	0.00354	CcSEcCtD
Zolmitriptan—Dysgeusia—Temozolomide—malignant glioma	0.00118	0.00346	CcSEcCtD
Zolmitriptan—Tremor—Carmustine—malignant glioma	0.00117	0.00343	CcSEcCtD
Zolmitriptan—Back pain—Temozolomide—malignant glioma	0.00117	0.00342	CcSEcCtD
Zolmitriptan—Agitation—Carmustine—malignant glioma	0.00115	0.00336	CcSEcCtD
Zolmitriptan—Tremor—Temozolomide—malignant glioma	0.00113	0.00331	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Temozolomide—malignant glioma	0.00112	0.00328	CcSEcCtD
Zolmitriptan—MAOA—brain—malignant glioma	0.00112	0.00372	CbGeAlD
Zolmitriptan—Leukopenia—Carmustine—malignant glioma	0.00112	0.00328	CcSEcCtD
Zolmitriptan—Agitation—Temozolomide—malignant glioma	0.00111	0.00325	CcSEcCtD
Zolmitriptan—Angioedema—Temozolomide—malignant glioma	0.0011	0.00323	CcSEcCtD
Zolmitriptan—Malaise—Temozolomide—malignant glioma	0.00109	0.00319	CcSEcCtD
Zolmitriptan—Vertigo—Temozolomide—malignant glioma	0.00109	0.00318	CcSEcCtD
Zolmitriptan—Convulsion—Carmustine—malignant glioma	0.00108	0.00317	CcSEcCtD
Zolmitriptan—Leukopenia—Temozolomide—malignant glioma	0.00108	0.00317	CcSEcCtD
Zolmitriptan—Hypertension—Carmustine—malignant glioma	0.00108	0.00316	CcSEcCtD
Zolmitriptan—Palpitations—Temozolomide—malignant glioma	0.00107	0.00313	CcSEcCtD
Zolmitriptan—Chest pain—Carmustine—malignant glioma	0.00107	0.00312	CcSEcCtD
Zolmitriptan—Myalgia—Carmustine—malignant glioma	0.00107	0.00312	CcSEcCtD
Zolmitriptan—Anxiety—Carmustine—malignant glioma	0.00106	0.00311	CcSEcCtD
Zolmitriptan—Cough—Temozolomide—malignant glioma	0.00105	0.00309	CcSEcCtD
Zolmitriptan—Convulsion—Temozolomide—malignant glioma	0.00105	0.00306	CcSEcCtD
Zolmitriptan—Hypertension—Temozolomide—malignant glioma	0.00104	0.00305	CcSEcCtD
Zolmitriptan—Confusional state—Carmustine—malignant glioma	0.00103	0.00301	CcSEcCtD
Zolmitriptan—Arthralgia—Temozolomide—malignant glioma	0.00103	0.00301	CcSEcCtD
Zolmitriptan—Myalgia—Temozolomide—malignant glioma	0.00103	0.00301	CcSEcCtD
Zolmitriptan—Anxiety—Temozolomide—malignant glioma	0.00103	0.003	CcSEcCtD
Zolmitriptan—Oedema—Carmustine—malignant glioma	0.00102	0.00299	CcSEcCtD
Zolmitriptan—Discomfort—Temozolomide—malignant glioma	0.00102	0.00298	CcSEcCtD
Zolmitriptan—Infection—Carmustine—malignant glioma	0.00101	0.00297	CcSEcCtD
Zolmitriptan—Dry mouth—Temozolomide—malignant glioma	0.00101	0.00295	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Carmustine—malignant glioma	0.001	0.00292	CcSEcCtD
Zolmitriptan—Tachycardia—Carmustine—malignant glioma	0.000996	0.00292	CcSEcCtD
Zolmitriptan—Confusional state—Temozolomide—malignant glioma	0.000995	0.00291	CcSEcCtD
Zolmitriptan—Oedema—Temozolomide—malignant glioma	0.000987	0.00289	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Temozolomide—malignant glioma	0.000987	0.00289	CcSEcCtD
Zolmitriptan—Infection—Temozolomide—malignant glioma	0.00098	0.00287	CcSEcCtD
Zolmitriptan—Anorexia—Carmustine—malignant glioma	0.000973	0.00285	CcSEcCtD
Zolmitriptan—Nervous system disorder—Temozolomide—malignant glioma	0.000968	0.00283	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Temozolomide—malignant glioma	0.000966	0.00283	CcSEcCtD
Zolmitriptan—Skin disorder—Temozolomide—malignant glioma	0.000958	0.0028	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Temozolomide—malignant glioma	0.000954	0.00279	CcSEcCtD
Zolmitriptan—Anorexia—Temozolomide—malignant glioma	0.000941	0.00275	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00093	0.00272	CcSEcCtD
Zolmitriptan—Insomnia—Carmustine—malignant glioma	0.000923	0.0027	CcSEcCtD
Zolmitriptan—Paraesthesia—Carmustine—malignant glioma	0.000917	0.00268	CcSEcCtD
Zolmitriptan—Dyspnoea—Carmustine—malignant glioma	0.00091	0.00266	CcSEcCtD
Zolmitriptan—Somnolence—Carmustine—malignant glioma	0.000908	0.00266	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000899	0.00263	CcSEcCtD
Zolmitriptan—Insomnia—Temozolomide—malignant glioma	0.000892	0.00261	CcSEcCtD
Zolmitriptan—Decreased appetite—Carmustine—malignant glioma	0.000888	0.0026	CcSEcCtD
Zolmitriptan—Paraesthesia—Temozolomide—malignant glioma	0.000886	0.00259	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Carmustine—malignant glioma	0.000881	0.00258	CcSEcCtD
Zolmitriptan—Dyspnoea—Temozolomide—malignant glioma	0.00088	0.00257	CcSEcCtD
Zolmitriptan—Somnolence—Temozolomide—malignant glioma	0.000877	0.00257	CcSEcCtD
Zolmitriptan—Pain—Carmustine—malignant glioma	0.000873	0.00255	CcSEcCtD
Zolmitriptan—Constipation—Carmustine—malignant glioma	0.000873	0.00255	CcSEcCtD
Zolmitriptan—Dyspepsia—Temozolomide—malignant glioma	0.000869	0.00254	CcSEcCtD
Zolmitriptan—Decreased appetite—Temozolomide—malignant glioma	0.000858	0.00251	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000852	0.00249	CcSEcCtD
Zolmitriptan—Constipation—Temozolomide—malignant glioma	0.000844	0.00247	CcSEcCtD
Zolmitriptan—Pain—Temozolomide—malignant glioma	0.000844	0.00247	CcSEcCtD
Zolmitriptan—Feeling abnormal—Carmustine—malignant glioma	0.000841	0.00246	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Carmustine—malignant glioma	0.000835	0.00244	CcSEcCtD
Zolmitriptan—Feeling abnormal—Temozolomide—malignant glioma	0.000813	0.00238	CcSEcCtD
Zolmitriptan—Body temperature increased—Carmustine—malignant glioma	0.000807	0.00236	CcSEcCtD
Zolmitriptan—Abdominal pain—Carmustine—malignant glioma	0.000807	0.00236	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Temozolomide—malignant glioma	0.000807	0.00236	CcSEcCtD
Zolmitriptan—Urticaria—Temozolomide—malignant glioma	0.000784	0.00229	CcSEcCtD
Zolmitriptan—Abdominal pain—Temozolomide—malignant glioma	0.00078	0.00228	CcSEcCtD
Zolmitriptan—Body temperature increased—Temozolomide—malignant glioma	0.00078	0.00228	CcSEcCtD
Zolmitriptan—Hypersensitivity—Carmustine—malignant glioma	0.000752	0.0022	CcSEcCtD
Zolmitriptan—Asthenia—Carmustine—malignant glioma	0.000733	0.00214	CcSEcCtD
Zolmitriptan—Hypersensitivity—Temozolomide—malignant glioma	0.000727	0.00213	CcSEcCtD
Zolmitriptan—Asthenia—Temozolomide—malignant glioma	0.000708	0.00207	CcSEcCtD
Zolmitriptan—Diarrhoea—Carmustine—malignant glioma	0.000699	0.00204	CcSEcCtD
Zolmitriptan—Pruritus—Temozolomide—malignant glioma	0.000698	0.00204	CcSEcCtD
Zolmitriptan—Dizziness—Carmustine—malignant glioma	0.000675	0.00198	CcSEcCtD
Zolmitriptan—Diarrhoea—Temozolomide—malignant glioma	0.000675	0.00198	CcSEcCtD
Zolmitriptan—Dizziness—Temozolomide—malignant glioma	0.000652	0.00191	CcSEcCtD
Zolmitriptan—Vomiting—Carmustine—malignant glioma	0.000649	0.0019	CcSEcCtD
Zolmitriptan—Rash—Carmustine—malignant glioma	0.000644	0.00188	CcSEcCtD
Zolmitriptan—Dermatitis—Carmustine—malignant glioma	0.000643	0.00188	CcSEcCtD
Zolmitriptan—Headache—Carmustine—malignant glioma	0.00064	0.00187	CcSEcCtD
Zolmitriptan—Vomiting—Temozolomide—malignant glioma	0.000627	0.00184	CcSEcCtD
Zolmitriptan—Rash—Temozolomide—malignant glioma	0.000622	0.00182	CcSEcCtD
Zolmitriptan—Dermatitis—Temozolomide—malignant glioma	0.000622	0.00182	CcSEcCtD
Zolmitriptan—Headache—Temozolomide—malignant glioma	0.000618	0.00181	CcSEcCtD
Zolmitriptan—Nausea—Carmustine—malignant glioma	0.000606	0.00177	CcSEcCtD
Zolmitriptan—Nausea—Temozolomide—malignant glioma	0.000586	0.00171	CcSEcCtD
Zolmitriptan—HTR1F—Signaling by GPCR—EGFR—malignant glioma	4.06e-05	0.000429	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CDKN2B—malignant glioma	4.05e-05	0.000428	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NCOR1—malignant glioma	4.03e-05	0.000426	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—YWHAE—malignant glioma	4.02e-05	0.000425	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NTRK2—malignant glioma	4.02e-05	0.000425	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FLT1—malignant glioma	4e-05	0.000423	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP3—malignant glioma	4e-05	0.000422	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CB—malignant glioma	3.99e-05	0.000421	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—DUSP6—malignant glioma	3.98e-05	0.000421	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CG—malignant glioma	3.96e-05	0.000419	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN2B—malignant glioma	3.96e-05	0.000419	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JAG1—malignant glioma	3.93e-05	0.000415	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTK2—malignant glioma	3.93e-05	0.000415	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CD—malignant glioma	3.92e-05	0.000414	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH3—malignant glioma	3.92e-05	0.000414	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCL8—malignant glioma	3.91e-05	0.000413	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—PIK3CA—malignant glioma	3.88e-05	0.00041	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HES1—malignant glioma	3.86e-05	0.000408	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FBXW7—malignant glioma	3.85e-05	0.000407	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTK2—malignant glioma	3.85e-05	0.000407	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NCOR1—malignant glioma	3.84e-05	0.000406	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—KRAS—malignant glioma	3.84e-05	0.000405	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCL8—malignant glioma	3.83e-05	0.000405	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—RAF1—malignant glioma	3.79e-05	0.0004	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HES1—malignant glioma	3.78e-05	0.000399	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BDKRB2—malignant glioma	3.78e-05	0.000399	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—F2—malignant glioma	3.76e-05	0.000397	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NCOR1—malignant glioma	3.76e-05	0.000397	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—FGF2—malignant glioma	3.75e-05	0.000396	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—IL2—malignant glioma	3.74e-05	0.000395	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—RAF1—malignant glioma	3.71e-05	0.000392	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CB—malignant glioma	3.7e-05	0.000391	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PDGFRA—malignant glioma	3.68e-05	0.000388	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—IL2—malignant glioma	3.66e-05	0.000387	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT2—malignant glioma	3.63e-05	0.000383	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CB—malignant glioma	3.62e-05	0.000382	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PDGFRA—malignant glioma	3.6e-05	0.00038	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CG—malignant glioma	3.6e-05	0.00038	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SPP1—malignant glioma	3.57e-05	0.000377	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCL8—malignant glioma	3.55e-05	0.000375	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—IDH2—malignant glioma	3.54e-05	0.000374	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PTPN11—malignant glioma	3.54e-05	0.000374	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—PIK3CA—malignant glioma	3.52e-05	0.000372	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH2—malignant glioma	3.51e-05	0.000371	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MDM2—malignant glioma	3.51e-05	0.000371	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RAF1—malignant glioma	3.5e-05	0.00037	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SPP1—malignant glioma	3.49e-05	0.000369	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CD—malignant glioma	3.48e-05	0.000368	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCL8—malignant glioma	3.48e-05	0.000368	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ERBB2—malignant glioma	3.46e-05	0.000366	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KNG1—malignant glioma	3.44e-05	0.000363	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CB—malignant glioma	3.42e-05	0.000361	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL2—malignant glioma	3.4e-05	0.000359	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TERT—malignant glioma	3.38e-05	0.000357	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.34e-05	0.000352	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.33e-05	0.000351	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL2—malignant glioma	3.32e-05	0.000351	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TERT—malignant glioma	3.31e-05	0.00035	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PDGFB—malignant glioma	3.3e-05	0.000349	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT2—malignant glioma	3.29e-05	0.000348	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FGFR1—malignant glioma	3.28e-05	0.000347	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CAV1—malignant glioma	3.28e-05	0.000347	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL8—malignant glioma	3.28e-05	0.000347	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NTRK1—malignant glioma	3.28e-05	0.000346	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HIF1A—malignant glioma	3.24e-05	0.000342	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PDGFB—malignant glioma	3.23e-05	0.000342	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FGFR1—malignant glioma	3.22e-05	0.00034	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT1—malignant glioma	3.17e-05	0.000335	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HIF1A—malignant glioma	3.17e-05	0.000335	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CD—malignant glioma	3.16e-05	0.000334	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CASP3—malignant glioma	3.14e-05	0.000332	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL2—malignant glioma	3.14e-05	0.000331	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CAV1—malignant glioma	3.13e-05	0.000331	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KDR—malignant glioma	3.09e-05	0.000327	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CAV1—malignant glioma	3.06e-05	0.000324	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP3—malignant glioma	3.05e-05	0.000322	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—IDH1—malignant glioma	3.04e-05	0.000321	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CB—malignant glioma	3.04e-05	0.000321	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KDR—malignant glioma	3.03e-05	0.00032	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN2B—malignant glioma	3.02e-05	0.000319	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CG—malignant glioma	2.99e-05	0.000316	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—F2—malignant glioma	2.98e-05	0.000315	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FN1—malignant glioma	2.98e-05	0.000315	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—malignant glioma	2.97e-05	0.000314	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PTEN—malignant glioma	2.95e-05	0.000312	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SPHK1—malignant glioma	2.94e-05	0.000311	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BAD—malignant glioma	2.94e-05	0.000311	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTK2—malignant glioma	2.93e-05	0.00031	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL8—malignant glioma	2.92e-05	0.000308	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FN1—malignant glioma	2.92e-05	0.000308	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—F2—malignant glioma	2.92e-05	0.000308	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOTCH1—malignant glioma	2.91e-05	0.000308	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARG—malignant glioma	2.89e-05	0.000305	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2C18—malignant glioma	2.88e-05	0.000305	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BAD—malignant glioma	2.88e-05	0.000304	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HES1—malignant glioma	2.88e-05	0.000304	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—malignant glioma	2.88e-05	0.000304	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NCOR1—malignant glioma	2.86e-05	0.000302	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CD80—malignant glioma	2.86e-05	0.000302	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOTCH1—malignant glioma	2.85e-05	0.000302	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APC—malignant glioma	2.85e-05	0.000301	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CG—malignant glioma	2.85e-05	0.000301	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—RAF1—malignant glioma	2.82e-05	0.000298	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGF—malignant glioma	2.82e-05	0.000298	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTPN11—malignant glioma	2.8e-05	0.000296	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CD80—malignant glioma	2.8e-05	0.000295	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APC—malignant glioma	2.79e-05	0.000295	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CG—malignant glioma	2.79e-05	0.000295	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL2—malignant glioma	2.79e-05	0.000295	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGF—malignant glioma	2.76e-05	0.000291	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CB—malignant glioma	2.76e-05	0.000291	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTPN11—malignant glioma	2.74e-05	0.00029	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PDGFRA—malignant glioma	2.74e-05	0.00029	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.72e-05	0.000287	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—BRAF—malignant glioma	2.68e-05	0.000283	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—malignant glioma	2.67e-05	0.000282	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SPP1—malignant glioma	2.66e-05	0.000281	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL8—malignant glioma	2.65e-05	0.00028	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—STAT3—malignant glioma	2.64e-05	0.000279	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CD—malignant glioma	2.63e-05	0.000278	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—BRAF—malignant glioma	2.62e-05	0.000277	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT2—malignant glioma	2.61e-05	0.000276	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EGFR—malignant glioma	2.6e-05	0.000274	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT2—malignant glioma	2.55e-05	0.00027	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EGFR—malignant glioma	2.54e-05	0.000269	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL2—malignant glioma	2.53e-05	0.000268	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TERT—malignant glioma	2.52e-05	0.000267	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CD—malignant glioma	2.51e-05	0.000265	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PIK3CA—malignant glioma	2.48e-05	0.000262	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.48e-05	0.000262	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PDGFB—malignant glioma	2.46e-05	0.00026	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CD—malignant glioma	2.45e-05	0.000259	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—KRAS—malignant glioma	2.45e-05	0.000259	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MYC—malignant glioma	2.45e-05	0.000259	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGFR1—malignant glioma	2.45e-05	0.000259	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PIK3CA—malignant glioma	2.43e-05	0.000257	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HIF1A—malignant glioma	2.41e-05	0.000255	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—KRAS—malignant glioma	2.4e-05	0.000254	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FGF2—malignant glioma	2.4e-05	0.000253	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EGFR—malignant glioma	2.4e-05	0.000253	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.39e-05	0.000253	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FGF2—malignant glioma	2.35e-05	0.000248	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CAV1—malignant glioma	2.33e-05	0.000247	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTT1—malignant glioma	2.33e-05	0.000246	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KDR—malignant glioma	2.31e-05	0.000244	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CB—malignant glioma	2.29e-05	0.000242	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—malignant glioma	2.27e-05	0.00024	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—KRAS—malignant glioma	2.27e-05	0.000239	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PIK3CA—malignant glioma	2.25e-05	0.000238	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MDM2—malignant glioma	2.24e-05	0.000237	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RAF1—malignant glioma	2.24e-05	0.000236	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FN1—malignant glioma	2.22e-05	0.000235	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—F2—malignant glioma	2.22e-05	0.000235	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ERBB2—malignant glioma	2.21e-05	0.000234	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3CA—malignant glioma	2.21e-05	0.000233	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MDM2—malignant glioma	2.2e-05	0.000232	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BAD—malignant glioma	2.2e-05	0.000232	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RAF1—malignant glioma	2.19e-05	0.000231	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS1—malignant glioma	2.19e-05	0.000231	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CB—malignant glioma	2.18e-05	0.000231	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.18e-05	0.00023	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH1—malignant glioma	2.17e-05	0.00023	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ERBB2—malignant glioma	2.17e-05	0.000229	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CB—malignant glioma	2.14e-05	0.000226	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CD80—malignant glioma	2.13e-05	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APC—malignant glioma	2.13e-05	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CG—malignant glioma	2.13e-05	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGF—malignant glioma	2.1e-05	0.000222	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL8—malignant glioma	2.1e-05	0.000222	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTPN11—malignant glioma	2.09e-05	0.000221	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3CA—malignant glioma	2.08e-05	0.00022	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL8—malignant glioma	2.06e-05	0.000217	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—BCHE—malignant glioma	2.03e-05	0.000215	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—malignant glioma	2.03e-05	0.000214	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TP53—malignant glioma	2.01e-05	0.000213	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CASP3—malignant glioma	2.01e-05	0.000212	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.01e-05	0.000212	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL2—malignant glioma	2.01e-05	0.000212	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—BRAF—malignant glioma	2e-05	0.000211	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—malignant glioma	1.99e-05	0.00021	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTEN—malignant glioma	1.98e-05	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CASP3—malignant glioma	1.97e-05	0.000208	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL2—malignant glioma	1.96e-05	0.000207	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT2—malignant glioma	1.95e-05	0.000206	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EGFR—malignant glioma	1.94e-05	0.000205	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—malignant glioma	1.9e-05	0.000201	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.9e-05	0.000201	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTEN—malignant glioma	1.89e-05	0.000199	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.88e-05	0.000199	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	1.87e-05	0.000197	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—malignant glioma	1.86e-05	0.000196	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	1.85e-05	0.000196	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTEN—malignant glioma	1.85e-05	0.000195	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—malignant glioma	1.84e-05	0.000195	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—KRAS—malignant glioma	1.83e-05	0.000193	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—malignant glioma	1.8e-05	0.00019	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGF2—malignant glioma	1.79e-05	0.000189	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—malignant glioma	1.7e-05	0.00018	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—malignant glioma	1.7e-05	0.00018	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—STAT3—malignant glioma	1.69e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	1.68e-05	0.000178	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MDM2—malignant glioma	1.67e-05	0.000177	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—malignant glioma	1.67e-05	0.000176	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RAF1—malignant glioma	1.67e-05	0.000176	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—STAT3—malignant glioma	1.65e-05	0.000175	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ERBB2—malignant glioma	1.65e-05	0.000174	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.64e-05	0.000173	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	1.63e-05	0.000172	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTP1—malignant glioma	1.62e-05	0.000171	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CAT—malignant glioma	1.57e-05	0.000166	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MYC—malignant glioma	1.57e-05	0.000166	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL8—malignant glioma	1.57e-05	0.000165	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MYC—malignant glioma	1.54e-05	0.000162	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGFR—malignant glioma	1.53e-05	0.000162	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	1.51e-05	0.00016	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGFR—malignant glioma	1.5e-05	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP3—malignant glioma	1.5e-05	0.000158	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL2—malignant glioma	1.5e-05	0.000158	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NCOR1—malignant glioma	1.49e-05	0.000157	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—KRAS—malignant glioma	1.45e-05	0.000153	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—KRAS—malignant glioma	1.42e-05	0.00015	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—malignant glioma	1.42e-05	0.00015	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTEN—malignant glioma	1.41e-05	0.000149	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3CA—malignant glioma	1.4e-05	0.000148	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—malignant glioma	1.37e-05	0.000145	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	1.33e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	1.3e-05	0.000138	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TP53—malignant glioma	1.29e-05	0.000136	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—malignant glioma	1.27e-05	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TP53—malignant glioma	1.26e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—STAT3—malignant glioma	1.26e-05	0.000133	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CAV1—malignant glioma	1.21e-05	0.000128	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MYC—malignant glioma	1.17e-05	0.000124	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.16e-05	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGFR—malignant glioma	1.14e-05	0.000121	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—malignant glioma	1.14e-05	0.000121	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.1e-05	0.000117	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—malignant glioma	1.09e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—KRAS—malignant glioma	1.08e-05	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—malignant glioma	1.06e-05	0.000113	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARG—malignant glioma	1.06e-05	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	9.93e-06	0.000105	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CD—malignant glioma	9.7e-06	0.000102	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TP53—malignant glioma	9.61e-06	0.000101	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CB—malignant glioma	8.45e-06	8.93e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—malignant glioma	8.38e-06	8.85e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—malignant glioma	8.11e-06	8.57e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTEN—malignant glioma	7.3e-06	7.72e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3CA—malignant glioma	5.15e-06	5.44e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—malignant glioma	4.21e-06	4.45e-05	CbGpPWpGaD
